RESUMEN

The coating of fertilizers by polymers is one of the most efficient tools for their slow and control release into soil. This strategy avoids excessive use of the fertilizers and increases their availability to the crops needs. In the present paper, hydro-soluble diammonium phosphates (DAP) fertilizer was double coated following the dip-coating process by chitosan-clay composites as inner coating and paraffin wax as an outer coating. The chitosan composite preparation and characterization were deeply investigated. The montmorillonite (MMT) clay incorporation as filler improves the water barrier diffusion, mechanical properties, and thermal stability of the composite. The combination of the swelling behavior of the chitosan-clay composite (inner coating) and the hydrophobic property of paraffin wax (outer coating) was confirmed by the water holding capacity evaluation and the phosphorus release essays in water and soil. Indeed, the phosphorus dissolution from the coated DAP granules was significantly delayed compared to the uncoated DAP. Moreover, the biodegradation study of composite material in soil and the biochemical oxygen demand (BOD) tests revealed that the coating system proposed could be considered as a carbon source for microorganisms after the fertilization process, which confirms its sustainability.

Asunto(s)

RESUMEN

Diabetic nephropathy (DN) is the main reason for end-stage renal disease. Microalbuminuria as the non-invasive available diagnosis marker lacks specificity and gives high false positive rates. To identify and validate biomarkers for DN, we used in the present study urine samples from four patient groups: diabetes without nephropathy, diabetes with microalbuminuria, diabetes with macroalbuminuria and proteinuria without diabetes. For the longitudinal validation, we recruited 563 diabetic patients and collected 1363 urine samples with the clinical data during a follow-up of 6 years. Comparative urinary proteomics identified four proteins Apolipoprotein A-I (APOA1), Beta-2-microglobulin (B2M), E-cadherin (CDH1) and Lithostathine-1-alpha (REG1A), which differentiated with high statistical strength (p < 0.05) between DN patients and the other groups. Label-free mass spectrometric quantification of the candidates confirmed the discriminatory value of E-cadherin and Lithostathine-1-alpha (p < 0.05). Immunological validation highlighted E-cadherin as the only marker able to differentiate significantly between the different DN stages with an area under the curve (AUC) of 0.85 (95%-CI: [0.72, 0.97]). The analysis of the samples from the longitudinal study confirmed the prognostic value of E-cadherin, the critical increase in urinary E-cadherin level was measured 20 ± 12.5 months before the onset of microalbuminuria and correlated significantly (p < 0.05) with the glomerular filtration rate measured by estimated glomerular filtration rate (eGFR).